Lenox Wealth Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-90
Closed -$1K 590
2020
Q1
$1K Hold
90
﹤0.01% 650
2019
Q4
$1K Hold
90
﹤0.01% 654
2019
Q3
$2K Buy
+90
New +$1.76K ﹤0.01% 484

Other funds holding ANGO

Lenox Wealth Advisors's ANGO Position: Q2 2020 in Review

Lenox Wealth Advisors sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 90 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in ANGO in Q3 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2019. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

  • Lenox Wealth Advisors reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
  • Lenox Wealth Advisors sold 90 AngioDynamics shares in Q2 2020, an estimated $1K.
  • Lenox Wealth Advisors first reported a position in AngioDynamics in Q3 2019 and held it in 3 quarters.
  • Lenox Wealth Advisors's AngioDynamics position peaked at $2K in Q3 2019.
  • 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Lenox Wealth Advisors's 13F filing for Q2 2020, filed 14 Jul 2020.